Next Article in Journal
Processes of Identification in Families Enrolled in a Childhood Obesity Intervention: A Qualitative Study of Identities and Roles
Previous Article in Journal
Effects of High-Fat Diet on the Gut Microbiota of Renalase Gene Knockout Mice
 
 
Article
Peer-Review Record

The Prevalence of Risk and Protective Factors for Noncommunicable Diseases (NCDs) among Brazilian Adults with Pre-Obesity and Obesity

Obesities 2022, 2(3), 317-325; https://doi.org/10.3390/obesities2030026
by Thaís C. M. Caldeira 1,*, Marcela M. Soares 1, Taciana M. de Sousa 2, Izabella P. A. Veiga 2, Luiza E. S. da Silva 1 and Rafael M. Claro 2
Reviewer 1:
Reviewer 2:
Obesities 2022, 2(3), 317-325; https://doi.org/10.3390/obesities2030026
Submission received: 19 August 2022 / Revised: 31 August 2022 / Accepted: 7 September 2022 / Published: 10 September 2022

Round 1

Reviewer 1 Report

Dear Authors, 

Your MS is well written exploring the prevalence of risk and protective factors for NCDs among Brazilian adults with pre-obesity and obesity and compare it to that of non-overweight adults 

You observed that adults with pre-obesity and obesity were more likely to perform risk factors related to sedentary behavior and less leisure-time physical activity (among adults with obesity) and active commuting (among adults with pre-obesity and obesity) and alcohol abuse. However, among adults with pre-obesity and obesity, a lower prevalence was observed in relation to the regular consumption of sweets and smoking. The identified risk and protective factors had a similar prevalence between 2013 and 2019. Brazilian adults with preobesity and obesity presented worrisome scenario regarding risk and protective factor for NCDs.

Conclusions are then important in clinical practice.

This represents the strength of the present study.

I have only minor suggestion. 

 

Introduction

I suggest adding in the Introduction, between lines 48 and 52 to add

the reference 

Cite Share

 

Epicardial Adipose Tissue: A Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation.

Tarsitano MG, Pandozzi C, Muscogiuri G, Sironi S, Pujia A, Lenzi A, Giannetta E.

Nutrients. 2022 Jul 17;14(14):2926. doi: 10.3390/nu14142926.

PMID: 35889883 

 

Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.

Feola T, Puliani G, Sesti F, Modica R, Centello R, Minotta R, Cannavale G, Di Meglio S, Di Vito V, Lauretta R, Appetecchia M, Colao A, Lenzi A, Isidori AM, Faggiano A, Giannetta E.

J Endocrinol Invest. 2022 Apr;45(4):849-857. doi: 10.1007/s40618-021-01715-0. Epub 2022 Jan 18.

PMID: 35040099

 

PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial.

Fiore D, Gianfrilli D, Giannetta E, Galea N, Panio G, di Dato C, Pofi R, Pozza C, Sbardella E, Carbone I, Naro F, Lenzi A, Venneri MA, Isidori AM.

J Clin Endocrinol Metab. 2016 Apr;101(4):1525-34. doi: 10.1210/jc.2015-4252. Epub 2016 Mar 10.

PMID: 26964730

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Please check the attached file.

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Good Job.

Back to TopTop